妇产科指南

订阅

MedSci主页 / 所有栏目 / 妇产科指南

2022 FIGO建议：产后出血的管理

2022-03-10 国际妇产科联盟 Int J Gynaecol Obstet

产后出血产科疾病

2022年3月，国际妇产科联盟(FIGO)发布了产后出血的管理建议，本文主要目的是更新产后出现管理的关键概念，并提供清晰准确的管理工具和指导。

中文标题：

2022 FIGO建议：产后出血的管理

英文标题：

FIGO recommendations on the management of postpartum hemorrhage 2022

发布机构：

国际妇产科联盟

发布日期：

2022-03-10

简要介绍：

2022年3月，国际妇产科联盟(FIGO)发布了产后出血的管理建议，本文主要目的是更新产后出现管理的关键概念，并提供清晰准确的管理工具和指导。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 FIGO建议：产后出血的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9ccdf1c002386189, title=2022 FIGO建议：产后出血的管理, enTitle=FIGO recommendations on the management of postpartum hemorrhage 2022, guiderFrom=Int J Gynaecol Obstet, authorId=0, author=, summary=2022年3月，国际妇产科联盟(FIGO)发布了产后出血的管理建议，本文主要目的是更新产后出现管理的关键概念，并提供清晰准确的管理工具和指导。, cover=https://img.medsci.cn/2022318/1647592685073_1608702.png, journalId=0, articlesId=null, associationId=938, associationName=国际妇产科联盟, associationIntro=国际妇产科联盟(FIGO)是妇产科学界的唯一世界性专业团体组织，成立于1954年，联合了世界各国和地区妇产科协会，是世界上最具影响力的妇产科组织，目前一共拥有来自五大洲124个国家和地区的成员团体，中华人民共和国中华妇产科学会于2000年加入国际妇产科联盟(FIGO)，2009年成为常务理事国。FIGO的目标是，提升妇女健康并改善妇产科诊疗标准和服务，组织全球范围内的安全母亲项目-旨在帮助减少发展中国家的产妇死亡率；每三年召开一次世界妇产科大会；出版国际妇产科杂志等。, copyright=0, guiderPublishedTime=Thu Mar 10 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年3月，国际妇产科联盟(FIGO)发布了产后出血的管理建议，本文主要目的是更新产后出现管理的关键概念，并提供清晰准确的管理工具和指导。</span></p>, tagList=[TagDto(tagId=25227, tagName=产后出血), TagDto(tagId=119394, tagName=产科疾病)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6339, appHits=304, showAppHits=0, pcHits=1021, showPcHits=6031, likes=0, shares=52, comments=5, approvalStatus=1, publishedTime=Sat Mar 19 15:35:00 CST 2022, publishedTimeString=2022-03-10, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Fri Mar 18 16:39:42 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 21:06:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 FIGO建议：产后出血的管理.pdf)])
2022 FIGO建议：产后出血的管理.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2122342, encodeId=2fd221223422e, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4df22221237, createdName=120ff824m16暂无昵称, createdTime=Tue Mar 28 20:51:22 CST 2023, time=2023-03-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1210005, encodeId=988d121000584, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49068104839, createdName=ms6000000787436259, createdTime=Sun Apr 10 11:20:03 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206646, encodeId=bc8b1206646ab, content=非常实用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/3a48c34747af460fa85fe02bc2a29cec/c69d63dc03174edcae5209bde48c5bb8.jpg, createdBy=5a935531864, createdName=小莉子, createdTime=Mon Mar 28 16:15:34 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204888, encodeId=e5741204888cc, content=谢谢，非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f26412854, createdName=辛丹丹, createdTime=Tue Mar 22 11:19:36 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204689, encodeId=3d1e1204689ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Mon Mar 21 19:20:49 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2023-03-28 120ff824m16暂无昵称 来自江苏省

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2122342, encodeId=2fd221223422e, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4df22221237, createdName=120ff824m16暂无昵称, createdTime=Tue Mar 28 20:51:22 CST 2023, time=2023-03-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1210005, encodeId=988d121000584, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49068104839, createdName=ms6000000787436259, createdTime=Sun Apr 10 11:20:03 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206646, encodeId=bc8b1206646ab, content=非常实用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/3a48c34747af460fa85fe02bc2a29cec/c69d63dc03174edcae5209bde48c5bb8.jpg, createdBy=5a935531864, createdName=小莉子, createdTime=Mon Mar 28 16:15:34 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204888, encodeId=e5741204888cc, content=谢谢，非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f26412854, createdName=辛丹丹, createdTime=Tue Mar 22 11:19:36 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204689, encodeId=3d1e1204689ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Mon Mar 21 19:20:49 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2022-04-10 ms6000000787436259

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2122342, encodeId=2fd221223422e, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4df22221237, createdName=120ff824m16暂无昵称, createdTime=Tue Mar 28 20:51:22 CST 2023, time=2023-03-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1210005, encodeId=988d121000584, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49068104839, createdName=ms6000000787436259, createdTime=Sun Apr 10 11:20:03 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206646, encodeId=bc8b1206646ab, content=非常实用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/3a48c34747af460fa85fe02bc2a29cec/c69d63dc03174edcae5209bde48c5bb8.jpg, createdBy=5a935531864, createdName=小莉子, createdTime=Mon Mar 28 16:15:34 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204888, encodeId=e5741204888cc, content=谢谢，非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f26412854, createdName=辛丹丹, createdTime=Tue Mar 22 11:19:36 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204689, encodeId=3d1e1204689ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Mon Mar 21 19:20:49 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2022-03-28 小莉子

    非常实用，谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2122342, encodeId=2fd221223422e, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4df22221237, createdName=120ff824m16暂无昵称, createdTime=Tue Mar 28 20:51:22 CST 2023, time=2023-03-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1210005, encodeId=988d121000584, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49068104839, createdName=ms6000000787436259, createdTime=Sun Apr 10 11:20:03 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206646, encodeId=bc8b1206646ab, content=非常实用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/3a48c34747af460fa85fe02bc2a29cec/c69d63dc03174edcae5209bde48c5bb8.jpg, createdBy=5a935531864, createdName=小莉子, createdTime=Mon Mar 28 16:15:34 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204888, encodeId=e5741204888cc, content=谢谢，非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f26412854, createdName=辛丹丹, createdTime=Tue Mar 22 11:19:36 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204689, encodeId=3d1e1204689ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Mon Mar 21 19:20:49 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2022-03-22 辛丹丹

    谢谢，非常好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2122342, encodeId=2fd221223422e, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4df22221237, createdName=120ff824m16暂无昵称, createdTime=Tue Mar 28 20:51:22 CST 2023, time=2023-03-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1210005, encodeId=988d121000584, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49068104839, createdName=ms6000000787436259, createdTime=Sun Apr 10 11:20:03 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206646, encodeId=bc8b1206646ab, content=非常实用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/3a48c34747af460fa85fe02bc2a29cec/c69d63dc03174edcae5209bde48c5bb8.jpg, createdBy=5a935531864, createdName=小莉子, createdTime=Mon Mar 28 16:15:34 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204888, encodeId=e5741204888cc, content=谢谢，非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f26412854, createdName=辛丹丹, createdTime=Tue Mar 22 11:19:36 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204689, encodeId=3d1e1204689ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Mon Mar 21 19:20:49 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2022-03-21 148a60abm39暂无昵称

    学习了

    0

相关指南

产后出血患者血液管理专家共识(2022年版)

中国输血协会临床输血学专业委员会 · 2022-01-30

2021 WHO建议：子宫球囊填塞术治疗产后出血

世界卫生组织(WHO,The World Health Organization) · 2021-04-16

血管内介入技术在产后出血防治中的应用专家共识（2019）

中国妇幼保健协会放射介入专业委员会 · 2019-12-10

妊娠合并结构异常性心脏病并发产后出血MDT管理专家共识

中国研究型医院学会(CRHA,Chinese Research Hospital Association) · 2019-05-10

2019 NATA共识声明：产科患者血液管理——产后出血的预防和治疗

国外妇产科相关专家组 · 2019-02-06

2018 WHO建议：应用子宫收缩剂预防产后出血

世界卫生组织(WHO,The World Health Organization) · 2018-12-20